Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1239 press releases before 2023
-
AstraZeneca PLC First Quarter Results 2009
-
US Food and Drug Administration Extends Review Timeline for Onglyza (Saxagliptin) New Drug Application
-
IRESSA (Gefitinib) Recommended for Approval for the Treatment of Non-Small Cell Lung Cancer in Europe
-
Court Grants AstraZeneca Temporary Restraining Order Against Apotex in Pulmicort Respules Patent Litigation
-
FDA Advisory Committee Recommendation on Seroquel XR Supplemental New Drug Applications
-
AstraZeneca Files Suit Against Apotex for a Declaratory Judgment of Infringement Against Pulmicort Respules Patents
-
Sale of AstraZeneca OTC Product Portfolio Cleared by Swedish Competition Authority
-
AstraZeneca Receives FDA Complete Response Letter on Symbicort for the Treatment of Asthma in Children 6 to 11 Years Old
-
David Brennan elected board chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA)
-
ONGLYZA (Saxagliptin) Cardiovascular Profile Acceptable According to FDA Advisory Committee
Latest articles and press releases
All of our latest press releases and articles are available to explore
